Literature DB >> 9043744

Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia.

A Kertesz1, W Davidson, H Fox.   

Abstract

OBJECTIVE: To utilize the diagnostic criteria of frontal lobe dementia (FLD).
METHODS: We studied 12 patients with FLD diagnosed clinically, with radiological confirmation in 10 and autopsy confirmation in 2; sixteen patients with Alzheimer's disease matched for stage and severity to FLD and 11 patients with depressive dementia were used as control groups. A 24-item Frontal Behavioral Inventory (FBI) using the most relevant behavioral manifestations of FLD was administered in these populations.
RESULTS: FLD patient scores on the FBI were much higher compared with control groups (AD and DD). Item analysis showed loss of insight, indifference, distractibility, personal neglect and apathy as the most frequent negative symptoms. Perseveration, disinhibition, inappropriateness, impulsivity, and irresponsibility were the most significant positive symptoms. An operational definition of FLD included a minimum FBI score of 27. Only one false positive was shown in the depressive group and none among the AD group, indicating little overlap between patient groups, and a high discriminating value of the FBI.
CONCLUSIONS: The FBI appears to be a useful diagnostic instrument and a method to operate the behavioral criteria of FLD. Further prospective studies are warranted to establish validity.

Entities:  

Mesh:

Year:  1997        PMID: 9043744     DOI: 10.1017/s0317167100021053

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  142 in total

Review 1.  Frontal lobe functions.

Authors:  C Chayer; M Freedman
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 5.081

2.  Neuroanatomical correlates of emotional blunting in behavioral variant frontotemporal dementia and early-onset Alzheimer's disease.

Authors:  Grace J Lee; Po H Lu; Michelle J Mather; Jill Shapira; Elvira Jimenez; Alex D Leow; Paul M Thompson; Mario F Mendez
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Authors:  Mandana Modirrousta; Bruce H Price; Bradford C Dickerson
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

4.  Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations.

Authors:  Robert Perneczky; Corina Pohl; Susanne Bornschein; Hans Förstl; Alexander Kurz; Janine Diehl-Schmid
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-03-03       Impact factor: 5.270

5.  Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia.

Authors:  Gabriel C Léger; Sarah J Banks
Journal:  Dement Geriatr Cogn Disord       Date:  2013-10-10       Impact factor: 2.959

6.  Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Sharon X Xie; David J Libon; Xingmei Wang; Lauren Massimo; Peachie Moore; Luisa Vesely; Alea Khan; Anjan Chatterjee; H Branch Coslett; Howard I Hurtig; Tsao-Wei Liang; Murray Grossman
Journal:  J Int Neuropsychol Soc       Date:  2009-12-11       Impact factor: 2.892

7.  Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia.

Authors:  Sarah Jane Banks; Sandra Weintraub
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

8.  Clinical Progression in Four Cases of Primary Progressive Apraxia of Speech.

Authors:  Rene L Utianski; Joseph R Duffy; Heather M Clark; Edythe A Strand; Sarah M Boland; Mary M Machulda; Jennifer L Whitwell; Keith A Josephs
Journal:  Am J Speech Lang Pathol       Date:  2018-11-21       Impact factor: 2.408

9.  Executive dysfunction and periventricular diffusion tensor changes in amnesic mild cognitive impairment and early Alzheimer's disease.

Authors:  Ta-Fu Chen; Ya-Fang Chen; Ting-Wen Cheng; Mau-Sun Hua; Hon-Man Liu; Ming-Jang Chiu
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

Review 10.  The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Authors:  Adam L Boxer; Michael Gold; Edward Huey; William T Hu; Howard Rosen; Joel Kramer; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; George Jackson; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven S Khachaturian; Margaret Sutherland; Susan Abushakra; Joseph Lewcock; Robert Farese; Robert O Kenet; Frank Laferla; Steve Perrin; Steve Whitaker; Lawrence Honig; Marsel M Mesulam; Brad Boeve; Murray Grossman; Bruce L Miller; Jeffrey L Cummings
Journal:  Alzheimers Dement       Date:  2012-10-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.